ReviewCancer drug resistance (Alhambra, Calif.)2023

How acute myeloid leukemia (AML) escapes from FMS-related tyrosine kinase 3 (FLT3) inhibitors? Still an overrated complication?

Salvatore Perrone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.